Lundbeck’s “Expand and Invest to Grow”, announced in 2019, builds on Lundbeck’s heritage of delivering essential medicines for brain diseases, leveraging our broad neuroscience expertise to expand the scope of brain diseases we are pursuing for the benefit of patients.